Clinical trial · Observational
Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs
Detection of Immune Cell Responses in Chronic HCV Patients Developing Hepatocellular Carcinoma After Treatment With Direct Acting Antiviral Drugs (DAAs)
NCT03602703CI-TRIAL-00044583completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Case control Study to assess the difference of immune cell responses between patients with chronic HCV- related liver cirrhosis who develop HCC after treatment with DAAs and those who do not develop HCC
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Drug-Induced Liver Injury | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Flow cytometry and Western Blot analysis | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- chronic HCV
- description
- chronic HCV either treated or not with DAAs.Flow cytometry and Western Blot analysis for each subgroup
- interventionNames
- Diagnostic Test: Flow cytometry and Western Blot analysis
- label
- Liver cirrhosis without HCC
- description
- Liver cirrhosis without HCC either received treatment or not.Flow cytometry and Western Blot analysis for each subgroup
- interventionNames
- Diagnostic Test: Flow cytometry and Western Blot analysis
- label
- Liver cirrhosis with HCC
- description
- Liver cirrhosis with HCC either received treatment or not.Flow cytometry and Western Blot analysis for each subgroup
- interventionNames
- Diagnostic Test: Flow cytometry and Western Blot analysis
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with HCC on top of HCV related liver cirrhosis either received treatment or not * Patients without HCC either received treatment or not . * Patients with chronic HCV as a control group either received treatment or not. Exclusion Criteria: * Patients with HCC who received any interventional treatment as alcohol injection, radiofrequency , TACE..etc * Patients with recurrent HCC after curative treatment.
References
Publications (0)
Data not yet available
No reference posted for this study.